We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
Results for
"[search-keyword]"
Sponsor content
16 result(s) found, displaying 1 to 10
-
Australian Public Assessment Report (AusPAR)Melatonin-Link, Immela, Melakso, Voquily (melatonin) has been approved for short-term treatment of jet lag in adults aged 18 and over, and for sleep disorders in children and adolescents with neurodevelopmental disorders.
-
Australian Public Assessment Report (AusPAR)AusPAR for Trecondi for the treatment of adults with acute myeloid leukaemia or myelodysplastic syndrome, and paediatric population with malignant and non-malignant haematological diseases.
-
-
-
-
-
-
Australian Public Assessment Report (AusPAR)AusPAR for Defitelio (defibrotide) for treatment of severe hepatic veno-occlusive disease in haematopoietic stem-cell transplantation.
-
Section 14, TGO91 consentProduct(s) approved for Supply with noncompliant labelling.
-
Section 14, TGO91 consentProduct(s) approved for Supply with noncompliant labelling.